Navigation Links
Keys for detecting cardiac rupture
Date:1/9/2012
This release is available in Spanish.
The cardiologist Aitor Jimnez has managed to gather and characterise in detail 110 cases of cardiac rupture (CR), after spending 22 years (1978-2000) gathering data at the Hospital de Cruces, near Bilbao. It is one of the broadest anatomical series described in this respect. CR is the most serious complication of acute myocardial infarction; it is not very common, but when it does occur, it is mortal in practically all cases. So prevention, although difficult, seems more feasible than cure. Thanks to Jimnez's study, CR risk factors have been detected "to be able to partly predict this complication and conduct more exhaustive monitoring." His thesis, which he defended at the University of the Basque Country (UPV/EHU), is entitled Rotura cardiaca en el infarto agudo de miocardio. Correlacin clnica y patolgica (Cardiac rupture in acute myocardial infarction. Clinical and pathological correlation).
In the cases in which CR occurs, it appears on average on the third day following the infarction. The infarcted wall tears, the blood rushes from the ventricular cavity into the pericardium. The latter cannot handle such a large quantity of blood, so it ends up compressing the heart and stopping it as a result of cardiac tamponade. The rate of CR only represents 1.5% of all the cases studied by Jimnez. However, if one looks only at the patients who end up dying following the infarction, CR turns out to be the cause of death in 29% of the cases.
They die within 20 minutes
The onset of this complication is, as Jimnez explains, sudden: "Once it takes place, the patient dies in 20 minutes. You diagnose it, but there's virtually nothing you can do. At the Hospital de Cruces, a very aggressive protocol has even been established. If CR is suspected, open the patient's thorax in situ an
'/>"/>
| Contact: Amaia Portugal a.portugal@elhuyar.com 34-943-363-040 Elhuyar Fundazioa Source:Eurekalert |
Related medicine news :
1. CT scans for lung cancer screening may be beneficial in detecting COPD
2. Detecting bath salts designer drug
3. Improved method for detecting mutant DNAs
4. Detecting glaucoma before it blinds
5. Annual Breast Exams, Mammograms Still Key to Detecting Breast Cancer
6. More Evidence CT Scans Better at Detecting Lung Cancer
7. Detecting lung cancer early
8. Radar shows promise for detecting concussions in athletes and soldiers
9. International training to assist governments of 5 African nations in detecting poor-quality drugs
10. Penn study suggests another avenue for detecting Alzheimers disease
11. Toward a fast, simple test for detecting cholera rampaging in 40 countries
Post Your Comments:
(Date:5/24/2013)... Mirena IUD lawyers at the Rottenstein Law Group are ... than 59,229 complaints since 2004 from women claiming they suffered ... as the Mirena IUD.* , Among the most common of ... where the IUD came out on its own. There are ... article. “Abdominal pain is also common, with 3,774 complaints. And ...
(Date:5/24/2013)... 24, 2013 Gift Card Network ... competitors in sustainable card material, are combining forces ... materials as a sustainable gift card substrate. , ... industry challenges and increase education and usage of ... support the reduction of carbon footprint and environmental ...
(Date:5/24/2013)... failed to replicate what appeared to be breakthrough results ... were published last year in the journal Science ... suggested that the drug bexarotene (marketed as Targretin) could ... a pathological hallmark of Alzheimer,s disease in ... the 2012 report, drug treatment quickly removed most of ...
(Date:5/24/2013)... Los Angeles, CA (PRWEB) May 24, 2013 ... is to present the 3rd Annual EB-5 Investment Summit: ... 2013. The Dealmakers Conference will focus on exploring alternative ... provide the latest market, legal and economic information, and ... legal professionals within the EB-5 industry. , "Our ...
(Date:5/24/2013)... 24, 2013 Mike Stoler believes that ... successful business people in New York. That’s why ... weekly on CUNY TV. And that’s why he ... Allergy Associates, LLP (ENTA)—the largest single specialty practice in ... throat, allergy and audiology specialists and sub-specialists service communities ...
Breaking Medicine News(10 mins):Health News:Sufferers of Alleged Mirena IUD Side Effects Lodge More Than 59,000 Complaints With FDA, Rottenstein Law Group LLP Notes 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 3Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 2Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 3Health News:Brian Su Organizes 3rd Annual EB-5 Investment Conference in Long Beach, California 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 3Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 4[0] Sufferers of Alleged Mirena IUD Side Effects Lodge More Than 59,000 Complaints With FDA, Rottenstein Law Group LLP Notes[0] Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants[0] Multiple research teams unable to confirm high-profile Alzheimer's study[0] Brian Su Organizes 3rd Annual EB-5 Investment Conference in Long Beach, California[0] Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York
... self esteem, SAUSALITO, Calif., May 14 When Peggy ... afraid to go to school,because she had lost her hair ... of her custom-made hair pieces and invited her and her,mother ... -- and raised the money to pay for it., ...
... Room Temperature Stable Treatment for Hemophilia With ... Convenience to Patients, PRINCETON, N.J., May 13 ... and Drug Administration (FDA) has approved,NovoSeven(R) RT (Coagulation ... temperature stable recombinant product available,for the treatment of ...
... the unmet needs of ... and communities, SACRAMENTO, Calif., May 13 The ... for the use of,traditional and technologically advanced forms of ... nonprofit charities. Founding,organizations for this new alliance include Disabled ...
... Promoting ... Healthy Workplace, ... Health, a national non-profit organization of large employers, today,honored Data ... healthy workplace and encouraging a healthy,lifestyle for its employees and ...
... demonstrating ... time since separation; strategic investments ... - Management updates financial guidance based on year to date performance ... and operational momentum, BATESVILLE, Ind., May 13 Hill-Rom Holdings,Inc. (NYSE: HRC ), reporting for ...
... - Third quarter fiscal 2008 revenue of $21.9 million versus $23.8 million ... in the same quarter last year. ... ... Natural,Alternatives International, Inc. ("NAI") (Nasdaq: NAII ), a leading,formulator, manufacturer and ...
Cached Medicine News:Health News:Teen Girl Loses Hair But Gains Support 2Health News:FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors 2Health News:FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors 3Health News:FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors 4Health News:Charities Form Alliance to Preserve and Improve Charity Bingo 2Health News:National Business Group on Health Honors Data Recognition Corporation as One of Best Employers for Healthy Lifestyles 2Health News:National Business Group on Health Honors Data Recognition Corporation as One of Best Employers for Healthy Lifestyles 3Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 2Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 3Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 4Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 5Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 6Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 7Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 8Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 9Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 10Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 11Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 12Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 13Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 14Health News:Natural Alternatives International, Inc. Announces Third Quarter Results 2Health News:Natural Alternatives International, Inc. Announces Third Quarter Results 3Health News:Natural Alternatives International, Inc. Announces Third Quarter Results 4Health News:Natural Alternatives International, Inc. Announces Third Quarter Results 5Teen Girl Loses Hair But Gains SupportFDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With InhibitorsCharities Form Alliance to Preserve and Improve Charity BingoNational Business Group on Health Honors Data Recognition Corporation as One of Best Employers for Healthy LifestylesHill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior YearNatural Alternatives International, Inc. Announces Third Quarter Results
(Date:5/23/2013)... Mass. , May 23, 2013 Haemonetics Corporation (NYSE: ... Lindop , CFO & EVP-Business Development, will present at ... Conference in Boston, MA on May ... http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) The public may access ... About Haemonetics Haemonetics (NYSE: ...
(Date:5/23/2013)... MGC Diagnostics Corporation (NASDAQ: MGCD ) ... scheduled a conference call to discuss its financial results ... April 30, 2013. The call will be at 4:30 ... will report financial results for the second quarter of ... May 30, 2013. (Logo: http://photos.prnewswire.com/prnh/20120821/LA60189LOGO ...
(Date:5/23/2013)... Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly ... property developed and owned by Hadassah University Hospital, ... center, today announced that its portfolio company, Cell ... Israeli Ministry of Industry and Commerce, Office of ... and advance clinical trials. Cell Cure,s development budget ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2[0] Haemonetics to Present at The Deutsche Bank 38th Annual dbAccess Health Care Conference[0] MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013[0] Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support
... Oct. 28 Octapharma Group and Fresenius Kabi ... regarding the use of Fresenius Kabi,s HESylation® Technology ... the agreement, Fresenius Kabi will license its proprietary ... based on hydroxyethyl starch ("HES") which will be ...
... , MALVERN, Pa., Oct. 28 Featuring the lowest ... Siemens Healthcare,s SOMATOM® Definition Flash dual-source computed tomography (CT) ... for Children, Orlando, Fla., to better serve its pediatric ... of the radiation dose that systems previously required to ...
Cached Medicine Technology:Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein 2Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein 3Siemens Delivers Flash Speed, Lowest Dose to Arnold Palmer Hospital for Children 2Siemens Delivers Flash Speed, Lowest Dose to Arnold Palmer Hospital for Children 3This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,408-9) or contact custom...
... ergonomic design reduces hand fatigue, prevents injury. Dry seal technology. No cleaning, ... 1-10 Inaccuracy (%) ... Imprecision(%) ... 0.1 Dimensions: ...
... Pipetman Ultra is a fully adjustable, air-displacement ... It is the latest member of the ... characteristics: robustness, accuracy, and precision. We also ... feedback from our customers. Eight models cover ...
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 2-20 microliter range....
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |